Caplen, Natasha J.
National Cancer Institute (NCI),
United States
2025 Rank: 84038
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3339 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84038 | 93539 |
| Total Cites | 8797 | 9510 |
| H-index | 38 | 40 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 243 | 246 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2450 | 2605 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 3387 | 3599 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8163 | 8669 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
7.50%
|
|
Caplen, Natasha J.
National Institutes of Health (NIH),
United States
2024 Rank: 78774
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3188 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78774 | 88113 |
| Total Cites | 8563 | 9255 |
| H-index | 38 | 40 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 237 | 240 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2408 | 2562 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 3288 | 3492 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7948 | 8441 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
7.48%
|
|
Caplen, Natasha J.
National Cancer Institute (NCI),
United States
2023 Rank: 74478
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 3070 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74478 | 83248 |
| Total Cites | 8317 | 9003 |
| H-index | 37 | 39 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 235 | 238 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2375 | 2530 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 3198 | 3399 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7718 | 8206 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
7.62%
|
|
Caplen, Natasha J.
National Cancer Institute (NCI),
United States
2022 Rank: 69398
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2882 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69398 | 78788 |
| Total Cites | 8010 | 8686 |
| H-index | 37 | 38 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 229 | 232 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2326 | 2481 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 3095 | 3294 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7428 | 7909 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
7.78%
|
|
Caplen, Natasha J.
National Cancer Institute (NCI),
United States
2021 Rank: 65915
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2764 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65915 | 74864 |
| Total Cites | 7829 | 8491 |
| H-index | 37 | 38 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 226 | 229 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2295 | 2444 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 3035 | 3226 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7263 | 7737 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
7.80%
|
|
Caplen, Natasha J.
National Cancer Institute,
United States
2020 Rank: 60767
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biotechnology
Rank in SubField 1: 2691 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60767 | 69680 |
| Total Cites | 7453 | 8081 |
| H-index | 36 | 37 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 222 | 225 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 2259 | 2399 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 2917 | 3089 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6894 | 7353 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
7.77%
|
|